These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 31723548)

  • 1. Nano-Antagonist Alleviates Inflammation and Allows for MRI of Atherosclerosis.
    Mog B; Asase C; Chaplin A; Gao H; Rajagopalan S; Maiseyeu A
    Nanotheranostics; 2019; 3(4):342-355. PubMed ID: 31723548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphodiesterase 3B (PDE3B) regulates NLRP3 inflammasome in adipose tissue.
    Ahmad F; Chung YW; Tang Y; Hockman SC; Liu S; Khan Y; Huo K; Billings E; Amar MJ; Remaley AT; Manganiello VC
    Sci Rep; 2016 Jun; 6():28056. PubMed ID: 27321128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gas6 Promotes Inflammatory (CCR2
    Laurance S; Bertin FR; Ebrahimian T; Kassim Y; Rys RN; Lehoux S; Lemarié CA; Blostein MD
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1315-1322. PubMed ID: 28450294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melatonin Ameliorates the Progression of Atherosclerosis via Mitophagy Activation and NLRP3 Inflammasome Inhibition.
    Ma S; Chen J; Feng J; Zhang R; Fan M; Han D; Li X; Li C; Ren J; Wang Y; Cao F
    Oxid Med Cell Longev; 2018; 2018():9286458. PubMed ID: 30254716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EGFP-EGF1-conjugated poly (lactic-co-glycolic acid) nanoparticles as a carrier for the delivery of CCR2- shRNA to atherosclerotic macrophage in vitro.
    Wu Z; Chen C; Luo J; Davis JRJ; Zhang B; Tang L; Shi W; Liao D
    Sci Rep; 2020 Nov; 10(1):19636. PubMed ID: 33184330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCL2, but not its receptor, is essential to restrict immune privileged central nervous system-invasion of Japanese encephalitis virus via regulating accumulation of CD11b(+) Ly-6C(hi) monocytes.
    Kim JH; Patil AM; Choi JY; Kim SB; Uyangaa E; Hossain FM; Park SY; Lee JH; Kim K; Eo SK
    Immunology; 2016 Oct; 149(2):186-203. PubMed ID: 27260136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma.
    Li X; Yao W; Yuan Y; Chen P; Li B; Li J; Chu R; Song H; Xie D; Jiang X; Wang H
    Gut; 2017 Jan; 66(1):157-167. PubMed ID: 26452628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ECL1i, d(LGTFLKC), a novel, small peptide that specifically inhibits CCL2-dependent migration.
    Auvynet C; Baudesson de Chanville C; Hermand P; Dorgham K; Piesse C; Pouchy C; Carlier L; Poupel L; Barthélémy S; Felouzis V; Lacombe C; Sagan S; Chemtob S; Quiniou C; Salomon B; Deterre P; Sennlaub F; Combadière C
    FASEB J; 2016 Jun; 30(6):2370-81. PubMed ID: 26979087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nf1+/- monocytes/macrophages induce neointima formation via CCR2 activation.
    Bessler WK; Kim G; Hudson FZ; Mund JA; Mali R; Menon K; Kapur R; Clapp DW; Ingram DA; Stansfield BK
    Hum Mol Genet; 2016 Mar; 25(6):1129-39. PubMed ID: 26740548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo MR evaluation of the effect of the CCR2 antagonist on macrophage migration.
    Lee Y; Ryu JW; Chang H; Sohn JY; Lee KW; Woo CW; Kang HJ; Jeong SY; Choi EK; Lee JS
    Magn Reson Med; 2010 Jul; 64(1):72-9. PubMed ID: 20572147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
    Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
    Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological inhibition of C-C chemokine receptor 2 decreases macrophage infiltration in the aortic root of the human C-C chemokine receptor 2/apolipoprotein E-/- mouse: magnetic resonance imaging assessment.
    Olzinski AR; Turner GH; Bernard RE; Karr H; Cornejo CA; Aravindhan K; Hoang B; Ringenberg MA; Qin P; Goodman KB; Willette RN; Macphee CH; Jucker BM; Sehon CA; Gough PJ
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):253-9. PubMed ID: 19965779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammation and NLRP3 Inflammasome Activation Initiated in Response to Pressure Overload by Ca
    Suetomi T; Willeford A; Brand CS; Cho Y; Ross RS; Miyamoto S; Brown JH
    Circulation; 2018 Nov; 138(22):2530-2544. PubMed ID: 30571348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the CCL2-CCR2 axis for atheroprotection.
    Georgakis MK; Bernhagen J; Heitman LH; Weber C; Dichgans M
    Eur Heart J; 2022 May; 43(19):1799-1808. PubMed ID: 35567558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles for the CX3CL1/CX3CR1 and CCL2/CCR2 Chemokine Systems in Hypoxic Pulmonary Hypertension.
    Amsellem V; Abid S; Poupel L; Parpaleix A; Rodero M; Gary-Bobo G; Latiri M; Dubois-Rande JL; Lipskaia L; Combadiere C; Adnot S
    Am J Respir Cell Mol Biol; 2017 May; 56(5):597-608. PubMed ID: 28125278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCL2/CCR2, but not CCL5/CCR5, mediates monocyte recruitment, inflammation and cartilage destruction in osteoarthritis.
    Raghu H; Lepus CM; Wang Q; Wong HH; Lingampalli N; Oliviero F; Punzi L; Giori NJ; Goodman SB; Chu CR; Sokolove JB; Robinson WH
    Ann Rheum Dis; 2017 May; 76(5):914-922. PubMed ID: 27965260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The molecular structure and role of CCL2 (MCP-1) and C-C chemokine receptor CCR2 in skeletal biology and diseases.
    Zhu S; Liu M; Bennett S; Wang Z; Pfleger KDG; Xu J
    J Cell Physiol; 2021 Oct; 236(10):7211-7222. PubMed ID: 33782965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colonic Pro-inflammatory Macrophages Cause Insulin Resistance in an Intestinal Ccl2/Ccr2-Dependent Manner.
    Kawano Y; Nakae J; Watanabe N; Kikuchi T; Tateya S; Tamori Y; Kaneko M; Abe T; Onodera M; Itoh H
    Cell Metab; 2016 Aug; 24(2):295-310. PubMed ID: 27508875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted delivery of CCR2 antagonist to activated pulmonary endothelium prevents metastasis.
    Roblek M; Calin M; Schlesinger M; Stan D; Zeisig R; Simionescu M; Bendas G; Borsig L
    J Control Release; 2015 Dec; 220(Pt A):341-347. PubMed ID: 26522070
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.